Physician

Daya S Sharma, MD

According to 2025 Medicare claims, Daya Sharma, MD (NPI: 1871527937) practices hematology/oncology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 20010-2989.

Sharma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 503 traditional Medicare patients, billed 126,643 HCPCS/CPT codes, and received $2,675,401 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,284 prescription claims across 157 beneficiaries totaling $5,082,256 in drug costs, led by Xtandi (Enzalutamide). DME data shows 24 claims. Open Payments data shows 131 records totaling $6,723. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,566,568 to $2,675,401. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,683,122 to $5,082,256. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$2.9M2015 Medicare payment: $1,566,568 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,599,419 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,290,107 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,068,658 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,324,867 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,607,204 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,618,909 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,940,993 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,436,576 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,675,401 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015739158,222$1,566,568
2016725154,032$1,599,419
2017725104,001$1,290,107
2018785139,666$2,068,658
2019765137,986$2,324,867
2020642152,594$2,607,204
2021590130,657$2,618,909
2022549146,645$2,940,993
2023553138,238$2,436,576
2024503126,643$2,675,401

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.5M$5.1M2015 Drug cost: $1,683,122 (USD; Tot_Drug_Cst)2016 Drug cost: $1,985,409 (USD; Tot_Drug_Cst)2017 Drug cost: $2,265,583 (USD; Tot_Drug_Cst)2018 Drug cost: $1,576,901 (USD; Tot_Drug_Cst)2019 Drug cost: $1,692,256 (USD; Tot_Drug_Cst)2020 Drug cost: $3,235,764 (USD; Tot_Drug_Cst)2021 Drug cost: $2,699,701 (USD; Tot_Drug_Cst)2022 Drug cost: $4,016,471 (USD; Tot_Drug_Cst)2023 Drug cost: $4,307,542 (USD; Tot_Drug_Cst)2024 Drug cost: $5,082,256 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151011,002$1,683,122
2016112870$1,985,409
2017113850$2,265,583
2018116935$1,576,901
2019120821$1,692,256
2020124979$3,235,764
2021108841$2,699,701
2022100830$4,016,471
2023121928$4,307,542
20241571,284$5,082,256

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$993$2.0K2018 Medicare payment: $1,083 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,986 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $992 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R24$1,083
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R48$1,986
2024N/R24$992

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes100102$146
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more280888$70
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes84303$67
99231Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes170637$42
36415Insertion of needle into vein for collection of blood sample253692$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide902,700$1,203,761
LenalidomideLenalidomide471,316$710,956
IbrancePalbociclib501,400$700,055
RevlimidLenalidomide30840$532,249
PomalystPomalidomide23644$527,694

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R12$821
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R12$171

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.131$6,723AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daya S. Sharma, MD?

Tedicare shows public-source Medicare data for Daya S. Sharma, MD (NPI 1871527937), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daya S. Sharma, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daya S. Sharma, MD?

Daya S. Sharma, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Daya S. Sharma, MD have Open Payments data?

Daya S. Sharma, MD has 131 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.